248 related articles for article (PubMed ID: 17985261)
1. The correlation between 1H-MR spectroscopy and clinical manifestation with tuberous sclerosis complex.
Matsuo N; Imamura A; Ito R; Sugawara K; Takahashi Y; Kondo N
Neuropediatrics; 2007 Jun; 38(3):126-9. PubMed ID: 17985261
[TBL] [Abstract][Full Text] [Related]
2. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
Dubey P; Fatemi A; Barker PB; Degaonkar M; Troeger M; Zackowski K; Bastian A; Smith SA; Pomper MG; Moser HW; Raymond GV
Neurology; 2005 Jan; 64(2):304-10. PubMed ID: 15668429
[TBL] [Abstract][Full Text] [Related]
3. Proton MR spectroscopy of cortical tubers in adults with tuberous sclerosis complex.
Mukonoweshuro W; Wilkinson ID; Griffiths PD
AJNR Am J Neuroradiol; 2001; 22(10):1920-5. PubMed ID: 11733326
[TBL] [Abstract][Full Text] [Related]
4. MR proton spectroscopy in patients with CNS involvement in Bourneville's disease.
Tarasów E; Kubas B; Walecki J
Med Sci Monit; 2001; 7(4):762-5. PubMed ID: 11433209
[TBL] [Abstract][Full Text] [Related]
5. High gamma-aminobutyric acid level in cortical tubers in epileptic infants with tuberous sclerosis complex measured with the MEGA-editing J-difference method and a three-Tesla clinical MRI Instrument.
Taki MM; Harada M; Mori K; Kubo H; Nose A; Matsuda T; Nishitani H
Neuroimage; 2009 Oct; 47(4):1207-14. PubMed ID: 19481612
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance spectroscopy and imaging of the thalamus in idiopathic generalized epilepsy.
Bernasconi A; Bernasconi N; Natsume J; Antel SB; Andermann F; Arnold DL
Brain; 2003 Nov; 126(Pt 11):2447-54. PubMed ID: 12902313
[TBL] [Abstract][Full Text] [Related]
7. Manually adjusted versus vendor-preset definition of metabolite boundaries impact on proton metabolite ratios.
Petrou M; Sundgren PC; Pang Y; Rohrer S; Foerster B; Chenevert TL
Acad Radiol; 2007 Mar; 14(3):340-3. PubMed ID: 17307667
[TBL] [Abstract][Full Text] [Related]
8. Neurological aspects of tuberous sclerosis in relation to MRI/MR spectroscopy findings in children with epilepsy.
Yapici Z; Dörtcan N; Baykan BB; Okan F; Dinçer A; Baykal C; Eraksoy M; Roach S
Neurol Res; 2007 Jul; 29(5):449-54. PubMed ID: 17609020
[TBL] [Abstract][Full Text] [Related]
9. MR spectroscopy in monitoring the treatment of Wilson's disease patients.
Tarnacka B; Szeszkowski W; Golebiowski M; Czlonkowska A
Mov Disord; 2008 Aug; 23(11):1560-6. PubMed ID: 18546325
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of brain metabolites observed by HRMAS 1H NMR of intact tissue and solution 1H NMR of tissue extracts in SIV-infected macaques.
Ratai EM; Pilkenton S; Lentz MR; Greco JB; Fuller RA; Kim JP; He J; Cheng LL; González RG
NMR Biomed; 2005 Jun; 18(4):242-51. PubMed ID: 15759297
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
[TBL] [Abstract][Full Text] [Related]
12. [Estimation of postmortem interval with single-voxel proton 1H-MR spectroscopy at different temperature].
Yang TT; Li ZW; Liu L; Zhen N
Fa Yi Xue Za Zhi; 2008 Apr; 24(2):85-9. PubMed ID: 18605034
[TBL] [Abstract][Full Text] [Related]
13. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
Pascual AM; Martínez-Bisbal MC; Boscá I; Valero C; Coret F; Martínez-Granados B; Marti-Bonmati L; Mir A; Celda B; Casanova B
Neurology; 2007 Jul; 69(1):63-7. PubMed ID: 17606882
[TBL] [Abstract][Full Text] [Related]
14. Proton MR spectroscopy of the foramen of Monro region in patients with tuberous sclerosis complex.
Carvalho-Neto Ad; Bruck I; Antoniuk SA; Marchiori E; Gasparetto EL
Arq Neuropsiquiatr; 2008 Jun; 66(2B):303-7. PubMed ID: 18641860
[TBL] [Abstract][Full Text] [Related]
15. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
16. Significance of tuber size for complications of tuberous sclerosis complex.
Pascual-Castroviejo I; Hernández-Moneo JL; Pascual-Pascual SI; Viaño J; Gutiérrez-Molina M; Velazquez-Fragua R; Quiñones Tapia D; Morales Bastos C
Neurologia; 2013; 28(9):550-7. PubMed ID: 23274119
[TBL] [Abstract][Full Text] [Related]
17. MRI, volumetry, 1H spectroscopy, and cerebropetal blood flowmetry in childhood idiopathic anatomic megalencephaly.
Koudijs SM; van der Grond J; Hoogendoorn ML; Hulshoff Pol HE; Schnack HG; Witkamp TD; Gooskens RH; van Nieuwenhuizen O; Braun KP
J Magn Reson Imaging; 2006 Aug; 24(2):282-7. PubMed ID: 16786580
[TBL] [Abstract][Full Text] [Related]
18. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
[TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopy reveals central neuroaxonal impairment in systemic sclerosis.
Bertinotti L; Mortilla M; Conforti ML; Colangelo N; Nacci F; Del Rosso A; Fonda C; Casale R; Matucci-Cerinic M; Pignone A
J Rheumatol; 2006 Mar; 33(3):546-51. PubMed ID: 16511924
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats.
Baik SK; Kim YW; Kim HJ; Lee JW; Cho BM; Kim DH; Choi SH; Lee SH; Chang KH
Acta Radiol; 2008 Dec; 49(10):1174-81. PubMed ID: 19031181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
